Atracurium Besylate (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Atracurium Besylate drug offered from Aurobindo Pharma Limited. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
NON-PROPRIETARY NAME: | Atracurium Besylate |
SUBSTANCE NAME: | ATRACURIUM BESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-04-08 |
END MARKETING DATE: | 0000-00-00 |
Atracurium Besylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Atracurium Besylate from Aurobindo Pharma Limited |
LABELER NAME: | Aurobindo Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/5mL) |
START MARKETING DATE: | 2015-04-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65862-984_5176be07-3121-49fb-9eb9-638903753a31 |
PRODUCT NDC: | 65862-984 |
APPLICATION NUMBER: | ANDA206010 |
Other ATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers: